LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q4 2024

SEC EDGAR SourceSEC Filings

Top Holdings264 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
??MICROSTRATEGY INCDelisted
Bond
323.1M$668.7M5.5%
Increased
81
369.7M$490.6M4.1%
New
87
??CONFLUENT INCDelisted
Bond
327.4M$295.1M2.4%
Increased
54
??LI AUTO INCDelisted
Bond
236.8M$271M2.2%
Increased
57
89.3M$260.8M2.2%
Increased
56
243.4M$252M2.1%
Increased
78
??INSMED INCDelisted
Bond
112.5M$244.5M2.0%
Decreased
0
286.1M$244.2M2.0%
Increased
54
87.5M$225M1.9%
Decreased
0
229M$221.7M1.8%
Increased
62
223.4M$221.3M1.8%
Increased
52
??SNAP INC
Bond
261.6M$214.3M1.8%
Increased
48
120M$212.4M1.8%
Increased
65
171.2M$204.8M1.7%
Increased
49
??ASCENDIS PHARMA ADelisted
Bond
169.2M$186.5M1.5%
Decreased
0
158.1M$163.3M1.4%
Increased
57
139.3M$152M1.3%
Increased
48
159.3M$149.2M1.2%
Unchanged
0
157.3M$146M1.2%
Unchanged
0
132M$143.5M1.2%
New
69
$12.1B
AUM
264
Positions
Q4 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
-13%Q4'22$9.5B-0%Q1'23$9.5B+0%Q2'23$9.5B+2%Q3'23$9.7B+8%Q4'23$10.5B+15%Q4'24$12.1B
Activity profile
$ moved · Q4'24
New28%Increased25%Decreased16%Exited30%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q20%1-4Q19%1-2Y22%2Y+39%

LINDEN ADVISORS LP manages $12.1B across 264 positions as of Q4 2024. Top holdings: MICROSTRATEGY INC (5.5%), WESTERN DIGITAL CORP (4.1%), CONFLUENT INC (2.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2024 Summary

Active quarter - 60 new positions, 73 exits, 56 increased. No standout high-conviction moves this quarter. Portfolio: $12.1B across 264 positions.

Top holdings by portfolio weight

Total AUM$12B
MICROSTRATEG5.54%
WESTERN DIGI4.07%
CONFLUENT IN2.45%
LI AUTO INC2.25%
<![CDATA[MAK2.16%
LIBERTY MEDI2.09%
INSMED INC2.03%
DRAFTKINGS I2.02%
UNITED STATE1.87%
LUMENTUM HLD1.84%
Other1.83%

Portfolio allocation by GICS sector

Sectors5
Unknown47.72%
Financial Services35.95%
Technology14.15%
Energy2.08%
Industrials0.10%

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q3 2024 Q2 2026+157.4M shares+$200.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used